Outcomes Of The Spanish Cohort Of Early Access To Pertuzumab And Trastuzumab Emtansine
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Neoplasms
Sponsor: BELEN RUIZ-ANTORAN